Related Experiment Video
Updated: Sep 23, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Tutorial: Statistical analysis and reporting of clinical pharmacokinetic studies
Ann-Cathrine Dalgård Dunvald1, Ditte Bork Iversen1, Andreas Ludvig Ohm Svendsen1
1Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
This tutorial guides early career researchers on designing and reporting clinical pharmacokinetic studies. It offers a step-by-step statistical analysis guide with R code for drug-drug interaction studies.
Area of Science:
- Pharmacology
- Clinical Research
- Statistical Analysis
Background:
- Pharmacokinetics (PK) is crucial for understanding drug behavior and response variability.
- Factors like drug-drug interactions (DDIs), pharmacogenetics, and organ function impact PK.
- A need exists for accessible guidelines on designing and analyzing clinical PK studies.
Purpose of the Study:
- To provide a comprehensive guideline and tutorial for designing clinical pharmacokinetic studies.
- To offer a step-by-step statistical analysis guide, including R code.
- To assist early career researchers in PK study design and reporting.
Main Methods:
- Development of a mock dataset simulating a DDI study.
- Detailed explanation of statistical analyses: sample size/power calculation, descriptive statistics, noncompartmental analysis, and hypothesis testing.
- Provision of complete R code for statistical analysis.
Main Results:
- A simulated DDI study dataset was created for illustrative purposes.
- Step-by-step statistical analysis procedures for clinical PK studies are detailed.
- A functional R code package is provided for practical application.
Conclusions:
- This tutorial offers a practical framework for designing and reporting clinical pharmacokinetic studies.
- The provided R code and methodology are adaptable for various PK study types beyond DDIs.
- It serves as a valuable resource for early career researchers entering the field of clinical pharmacokinetics.
More Related Videos
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...